Physician

Kimberly Carhuatanta, DO PHD

According to 2025 Medicare claims, Kimberly Carhuatanta, DO PHD (NPI: 1003445958) practices family practice in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 47025-2048. Carhuatanta is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Carhuatanta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 115 traditional Medicare patients, billed 586 HCPCS/CPT codes, and received $31,126 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,146 prescription claims across 197 beneficiaries totaling $103,905 in drug costs, led by Ozempic (Semaglutide). Open Payments data shows 71 records totaling $1,218. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $252 to $103,905. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$16K$31K2024 Medicare payment: $31,126 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024115586$31,126

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$52K$104K2020 Drug cost: $252 (USD; Tot_Drug_Cst)2021 Drug cost: $4,428 (USD; Tot_Drug_Cst)2022 Drug cost: $9,302 (USD; Tot_Drug_Cst)2023 Drug cost: $19,395 (USD; Tot_Drug_Cst)2024 Drug cost: $103,905 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R13$252
20212477$4,428
202235137$9,302
202370241$19,395
20241971,146$103,905

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more61113$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more57128$63
98928Osteopathic manipulative treatment, 7-8 body regions1837$50
98927Osteopathic manipulative treatment, 5-6 body regions1737$43
36415Insertion of needle into vein for collection of blood sample1416$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide20756$25,132
EliquisApixaban23678$14,439
JardianceEmpagliflozin18596$12,736
MyrbetriqMirabegron13498$7,853
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22318$2,279

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.71$1,218ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kimberly Carhuatanta, DO PHD?

Tedicare shows public-source Medicare data for Kimberly Carhuatanta, DO PHD (NPI 1003445958), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kimberly Carhuatanta, DO PHD have ACO affiliation data?

Kimberly Carhuatanta, DO PHD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Kimberly Carhuatanta, DO PHD?

Kimberly Carhuatanta, DO PHD is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Kimberly Carhuatanta, DO PHD have Open Payments data?

Kimberly Carhuatanta, DO PHD has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.